{
    "code": 0,
    "data": [
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Tuesday January 20 2026 for Q3FY26",
            "news_id": "2667edc3-0d77-455c-a440-ecf26e0ed220",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb349c3f-3a5a-4bfc-b22b-b952b3cda929.pdf",
            "news_date": "2026-01-27 18:15:35",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31 2025.",
            "news_id": "9fc19df5-f51a-4702-ab87-4584131167c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=149d8c3c-c868-4c2b-9756-b4a008c7bb71.pdf",
            "news_date": "2026-01-20 19:00:14",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q3&9MFY26.",
            "news_id": "28c28f5c-411f-49cc-a5ac-b86e27715c89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e0dcb04-9670-4851-a381-cf5c0a5d34fd.pdf",
            "news_date": "2026-01-20 15:23:44",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the results for quarter and nine months ended December 31 2025",
            "news_id": "44df71ab-5e9d-49f2-aa5a-15d1efd58892",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4eaecfe-32ba-4b3a-97fd-91c220de08af.pdf",
            "news_date": "2026-01-20 13:37:35",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Audio Recording of Business Update Call",
            "news_id": "5210e64b-2c52-4274-af80-551580743247",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fccbd3c-3ef3-49ca-bca7-acd092f7d6dd.pdf",
            "news_date": "2025-12-16 16:44:06",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Business update presentation",
            "news_id": "45e1976e-2971-48fb-945d-41d8794f2a74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a2c9f77-55fb-4efe-b3f1-530983767dc2.pdf",
            "news_date": "2025-12-15 19:54:28",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Thursday November 06 2025 for Q2 & H1FY26",
            "news_id": "29b2d096-2fed-4756-abf0-febacba850aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d6b5c6b-9d5b-417e-ac82-3aec59682705.pdf",
            "news_date": "2025-11-13 11:08:06",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange  regarding link of Audio recording of Earnings Conference Call for quarter and half year ended September 30 2025",
            "news_id": "d00d15aa-8c6c-448b-835f-f9feea2c55b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eb9728d-bb3a-4488-90c6-1ce5f0653697.pdf",
            "news_date": "2025-11-06 19:55:12",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q2 & H1FY26",
            "news_id": "b0c98034-5cad-41d6-97eb-afe5ba85bf63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce4efec9-6bad-4249-90d2-721dcdb9caae.pdf",
            "news_date": "2025-11-06 14:18:37",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange the results for Quarter and half year ended September 302025",
            "news_id": "b249323d-29f3-4e0d-8cf4-517893d0ecdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54268f95-c854-4a67-a638-034be381c495.pdf",
            "news_date": "2025-11-06 14:04:38",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conference Call held on Thursday July 24 2025 for Q1FY26.",
            "news_id": "8365c5fa-d683-47d4-af56-b969f969099e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ad0fa0-3887-47a6-a7ec-cd78979980ab.pdf",
            "news_date": "2025-07-30 16:37:08",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Link of Audio recording of Earnings Conference Call for quarter ended June 30 2025",
            "news_id": "0e5c857d-19f5-41c8-8ab6-791dfae1e3be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715b10a1-8445-4ccc-ba7e-502a738afbad.pdf",
            "news_date": "2025-07-24 18:18:45",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q1FY26.",
            "news_id": "fdcd2936-2164-41b2-8587-fc38e95cba6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac708ea4-5002-47b3-9d76-4bc491661e1f.pdf",
            "news_date": "2025-07-23 20:15:03",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended On June 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Un-audited Standalone and Consolidated Financial Results for quarter ended on June 30 2025.",
            "news_id": "82ea23c2-fc50-406b-9fc4-71a849253be6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c48bc9ab-ce84-42b4-be3c-978c934d0737.pdf",
            "news_date": "2025-07-23 18:49:13",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Transcript of Earnings Conference Call held on Friday May 16 2025 for Q4FY25",
            "news_id": "e22b0182-8231-4bdd-8d1f-c2b62618981a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da94862-93c4-4ac7-9508-a7e51a4203b1.pdf",
            "news_date": "2025-05-22 19:27:45",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding about Link of Audio recording of Earnings Conference Call for quarter and financial year ended March 31 2025.",
            "news_id": "c9e981b0-b9d1-4405-8870-5e1ef0ab718e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43e6850e-86ab-4f1f-84f5-71d8306ef077.pdf",
            "news_date": "2025-05-16 19:01:07",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Audited Standalone and Consolidated financial results for quarter and financial year ended March 31 2025",
            "news_id": "7f5187ea-bb62-4198-8dfd-80a28d9ac422",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ce7feff-eec5-4252-8dad-385809367244.pdf",
            "news_date": "2025-05-16 18:44:07",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q4 and FY25",
            "news_id": "7d3744d0-e244-423f-9bde-85206175de07",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673ded1e-4680-446d-8ae0-b9609a20598e.pdf",
            "news_date": "2025-05-16 15:44:22",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q4 and FY25.",
            "news_id": "5f1782aa-fb01-4a2f-a966-123135b6bcb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46eafcf0-b828-46cb-975a-3c3bf038e3d2.pdf",
            "news_date": "2025-05-16 14:25:17",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conference Call held on January 23 2025.",
            "news_id": "a5016de4-3788-479f-9bfd-8327391ba410",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf3f9dc-057c-43d5-8211-433755b6b5e1.pdf",
            "news_date": "2025-01-30 11:55:50",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Nine Months Ended December 31 2024",
            "news_body": "Results for quarter and nine months ended December 31 2024.",
            "news_id": "3d37f95f-da25-4279-a12c-85f4e258f36b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=338ae28d-3377-47fc-987c-ec57a05678ae.pdf",
            "news_date": "2025-01-23 13:55:08",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}